The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies/An T

Please use this identifier to cite or link to this item: http://dspace.hmtu.edu.vn/handle/DHKTYTHD_123/12301

Full metadata record

DC Field	Value	Language
dc.contributor.author	WuID, Chen-Yu	-
dc.date.accessioned	2022-05-05T00:27:55Z	-
dc.date.available	2022-05-05T00:27:55Z	-
dc.date.issued	2019	-
dc.identifier.uri	http://dspace.hmtu.edu.vn/handle/DHKTYTHD_123/12301	-
dc.description	Chính văn tài liệu	vi
dc.language.iso	en	vi
dc.publisher	PLOS ONE	vi
dc.subject	seroconversion	vi
dc.subject	antibodies	vi
dc.title	The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies/An T	vi
dc.type	Article	vi
Appears in Collections	Tạp chí Tiếng anh Y khoa

Files in This Item:

File	Description	Size	Format
213. The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies..pdf Restricted Access		815.97 kB	Adobe PDF	Request Item